DAU Low Cutoff 1

Product #50702

Add to Cart Personalize
Analyte Gravimetrically Weighted Value Units Stability (Days)
α-Hydroxyalprazolam 150 ng/mL 25 days
Amobarbital 150 ng/mL 25 days
d-Amphetamine 187.5 ng/mL 25 days
(±)-3,4-Methylenedioxyamphetamine (MDA) 187.5 ng/mL 25 days
d-Methamphetamine 187.5 ng/mL 25 days
(±)-3,4-Methylenedioxymethamphetamine (MDMA) 187.5 ng/mL 25 days
(±)-3,4-Methylenedioxyethylamphetamine (MDEA) 187.5 ng/mL 25 days
Benzoylecgonine 75 ng/mL 25 days
Butalbital 150 ng/mL 25 days
Codeine 225 ng/mL 25 days
Nordiazepam 150 ng/mL 25 days
Hydrocodone New 75 ng/mL 25 days
Hydromorphone New 75 ng/mL 25 days
Lorazepam 150 ng/mL 25 days
Methadone 150 ng/mL 25 days
Methadone Primary Metabolite (EDDP) 150 ng/mL 25 days
Methaqualone 150 ng/mL 25 days
Morphine-3-β-D-Glucuronide 365
(Equivalent to 225 free Morphine)
ng/mL 25 days
6-Monoacetylmorphine (6-MAM) 7.5 ng/mL 25 days
Nortriptyline 150 ng/mL 25 days
Oxazepam 150 ng/mL 25 days
Oxycodone New 37.5 ng/mL 25 days
Oxymorphone New 37.5 ng/mL 25 daus
Pentobarbital 150 ng/mL 25 days
Phencyclidine (PCP) 18.75 ng/mL 25 days
Phenobarbital 150 ng/mL 25 days
Norpropoxyphene 150 ng/mL 25 days
Secobarbital 150 ng/mL 25 days
Temazepam 150 ng/mL 25 days
(l)-9-Carboxy-11-nor-Delta-9-THC (THC-COOH) 11.25 ng/mL 25 days

Product Contains: α‑Hydroxyalprazolam, Amobarbital, d‑Amphetamine, (±)‑3,4‑Methylenedioxyamphetamine (MDA), d‑Methamphetamine, (±)‑3,4‑Methylenedioxymethamphetamine (MDMA), (±)‑3,4‑Methylenedioxyethylamphetamine (MDEA), Benzoylecgonine, Butalbital, Codeine, Nordiazepam, Lorazepam, Methadone, Methadone Primary Metabolite (EDDP), Methaqualone, Morphine‑3‑β‑D‑Glucuronide, 6‑Monoacetylmorphine (6‑MAM), Nortriptyline, Oxazepam, Pentobarbital, Phencyclidine (PCP), Phenobarbital, Norpropoxyphene, Secobarbital, Temazepam, (l)‑9‑Carboxy‑11‑nor‑Delta‑9‑THC (THC‑COOH)

Matrix Urine
Unit Size 4x10mL
Form Lyophilized
Shelf Life 30 months
Stability 25 days
Storage Store dried control material at 2-8ºC (35-46ºF).

Personalize the "DAU Low Cutoff 1" QC For Your Lab (Your Control, Your Way)

  • Personalized QC starts here. Your answers will help us deliver exactly what you need.
  • Matrix samples allow you to screen the starting material, prior to manufacturing, for interference with your test method or analytes of interest that are not tested in our in house ELISA screen. Adding a matrix sample to the order typically adds 1-2 weeks to the manufacturing lead time and can increase the per vial price of the material. Matrix samples are required when the analytes of interest are endogenous to the human body, to determine a baseline reading prior to manufacturing.
  • We manufacture and spike products gravimetrically; we do not test in-house to confirm concentration. We have been making products this way for over 40 years and are confident in our manufacturing accuracy. However, if you select this option, we will send this product to a 3rd party lab and provide a single run reference point confirming the concentration of the material. This process will extend the manufacturing lead time by 3-4 weeks. The actual cost each test will be included on your quote. We guarantee our products whether you select this service or not. If you have any issues with your material please contact us for support.
  • If you select this option we will send you 1 vial of each level of this product after manufacturing completes, to test for approval prior to shipping the full order. Once you have completed the approval process, there will be an approximate lead time of 1-3 business days to receive your full order. There is no charge for this service. We guarantee our products and we will support you with any issues regardless of whether you request a validation sample or not.
  • Drop files here or
    Accepted file types: pdf, csv, xlsx, .
  • AnalyteLevel 1Level 2Level 3Level 4Level 5ng/mL 
  • If you don't have a vial or label preference, the Control Freaks can choose for you.
  • Please note that our minimum order is 50mL per level.


For the purposes of drugs of abuse screening it is necessary to have a set of controls with high, intermediate and low drug concentrations. These cutoff controls allow identification of various levels of abuse.


Urine SDS | Download PDF
IFU for Lot #C8341 | Download PDF

Sign Up for Weekly Updates